spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

On Helix 2018

On_Helix_2018

10-11 July 2018
The Cambridge Building, Babraham Research Campus

ON Helix is One Nucleus' translational research conference for the Life Sciences industry.

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

The annual translational research conference, ON Helix aims to inform delegates of how to turn early stage inventions and ideas into innovative health treatments such as new medicines, novel biomarkers and medical devices, all aimed at improving medical practice. 

One Nucleus’ flagship Cambridge conference has moved to the Babraham Research Campus and is now a two day event. The growth of the conference allows for greater opportunities to debate the key challenges along the journey from discovery to first in man. 

Keynote Sessions will kick off both days. Each day will then break off into three parallel streams, consisting of panel debates, case studies, deal showcases, scientific talks and fireside chats. Day One will culminate with a Plenary Session and Conference Drinks Reception, open to ALL conference delegates. A great opportunity to meet those that may otherwise be attending a different day!  

Full details of the conference can be found at onhelix.com

phone +44 (0) 1223 896 450
email info@onenucleus.com
web onenucleus.com
email The Cambridge Building, Babraham Research Campus
 
Print this page
Send to a friend
   
spacer
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan Banner of PHPL West Coast_events_95 on Samedan

White Papers

Digital Transformation of the Cold Chain

Sensitech EMEA

The Life Sciences cold chain is a seamless and interconnected global network of people, equipment, data and processes that helps to ensure the safety and integrity of our medicines and vaccines. Cold chain logistics spending totaled $13 billion in 2017, an investment designed to protect some $283 billion in Life Sciences cold chain products, growing at 19% annually.1 Sensitech Inc., a part of UTC Climate, Controls & Security, a unit of United Technology Corp., has played an essential part in the Life Sciences cold chain since 1990, providing a comprehensive set of solutions for manufacturers of biologics, prescription pharmaceuticals, clinical trial materials, and over-the-counter drugs. These solutions help to ensure product quality, patient safety, and regulatory compliance while helping to prevent theft and optimizing cold chain performance.
More info >>


News and Press Releases

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Philadelphia, USA – October 15, 2018. Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the completion of a dedicated Returns Management facility at its Clinical Services Center of Excellence at Bridgend, UK. PCI provides a full service Returns Management service for clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a clinical study. Returning and reconciling Investigational Medicinal Product (IMP) on completion of a study is a critical part of a Clinical trial and can require complex reverse logistics. Trial outcomes can be impacted if Returns are not processed efficiently and precisely.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement